Medication info
Dear Medi Tablet 4 mg (Glimpiride)

Dear Medi Tablet 4 mg (Glimpiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›4mg / 1 tablet
Manufacturer / importer
Samchundang Pharm. Co., Ltd.
Appearance
Light blue rectangular tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201306527 · Approved 2013.03.29 · Insurance code 651203860

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional effect, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1 ~ 2-week intervals. Consider the potency and duration of action of the previous medicine. 4) Dose monitoring During treatment with this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycosylated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by consuming sugar. Hypoglycemia may recur despite successful initial management during treatment with a sulfonylurea. Therefore, monitor patients closely. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization may sometimes be necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Adjust the insulin dose periodically while measuring blood glucose and glycosylated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate caution should be exercised.

Ingredients

Manufacturer
Samchundang Pharm. Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Blood sugar control issues in patients with type 2 diabetes
View approved original text

This medication is used in conjunction with diet and exercise to assist in blood sugar control in patients with type 2 diabetes. It can be administered alone, but if blood sugar is not adequately controlled, it may be combined with insulin or other oral hypoglycemic agents like sulfonylureas or metformin. This combination therapy can improve blood sugar control more effectively.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional effect, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1 ~ 2-week intervals. Consider the potency and duration of action of the previous medicine. 4) Dose monitoring During treatment with this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycosylated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by consuming sugar. Hypoglycemia may recur despite successful initial management during treatment with a sulfonylurea. Therefore, monitor patients closely. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization may sometimes be necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Adjust the insulin dose periodically while measuring blood glucose and glycosylated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate caution should be exercised.

Precautions

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a coma. Additionally, patients who have had allergic reactions to this medication, sulfonylureas, or sulfonamides should not take it. There is no experience in usage for patients with severe liver or kidney impairment, thus switching to insulin therapy is recommended. Pregnant women, women who may become pregnant, and nursing mothers should not take this medication. Patients with severe infections, surgery, or serious trauma should also be treated with insulin. When gastrointestinal disorders such as diarrhea or vomiting occur, absorption of medication may be reduced, increasing the risk of hypoglycemia, so caution is needed. During the first week of taking this medication, there is a high risk of hypoglycemia, so blood sugar should be checked frequently and closely monitored. Particularly, older adults, patients with poor nutritional status or irregular eating patterns, those with mismatched exercise and carbohydrate intake, changes in meal patterns, or those who frequently consume alcohol should be extra cautious. Patients with weak kidney or liver function, those who overdose on this medication, or those with thyroid or adrenal dysfunction are also at higher risk for hypoglycemia and should be careful. Moreover, when taking with other medications, interactions can affect blood sugar control, so it is essential to inform doctors or pharmacists. The most common side effect while taking this medication is hypoglycemia, which may present as headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, or decreased consciousness. If symptoms of hypoglycemia occur, sugar should be taken immediately, and if symptoms are severe, medical assistance should be sought. Additionally, temporary blurred vision, nausea, vomiting, and abdominal pain may occur as gastrointestinal symptoms. Serious side effects such as liver dysfunction or decreased blood cell counts may rarely occur; consult a doctor immediately if abnormal symptoms arise. Allergic reactions such as skin rash, hives, or difficulty breathing may occur, and if these symptoms appear, discontinue the medication and visit a healthcare facility immediately. When taking this medication, regular meals, exercise, and weight management are crucial, and blood sugar control status should be monitored continuously. If hypoglycemia occurs, quickly raise blood sugar by consuming sugar or sugary drinks; artificial sweeteners will not be effective. In special circumstances such as stress, injury, surgery, or infection, blood sugar control may become difficult, and temporary switching to insulin therapy may be necessary. If other diseases arise or lifestyle changes occur while taking this medication, consult a doctor to adjust dosage or administration method. This medication is excreted through the kidneys, so elderly patients or those with impaired kidney function should be especially cautious regarding dosage adjustments. In the event of overdose, severe hypoglycemia may occur, requiring immediate emergency measures, which may include inducing vomiting, gastric lavage, or glucose injection. The safety and efficacy of this medication have not been established for children, so it should not be used in individuals under 18 years of age. Pregnant or nursing women should not take this medication, and switching to insulin therapy is advisable if necessary. When storing this medication, keep it out of reach of children and store it sealed in the original container. Finally, when taking this medication alongside other medications or discontinuing them, it may affect blood sugar control, so it is crucial to inform healthcare professionals and follow their instructions.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbances, anxiety, aggression, decreased concentration, decreased agility or motivation, depression, confusion, speech abnormalities, aphasia, visual disturbances, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, transient mental confusion, seizures, drowsiness, loss of consciousness, stupor, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep venous thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, shortness of breath, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering, and it is important to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. This storage method helps safely maintain the medication's efficacy.

Appearance and packaging

Appearance

Light blue rectangular tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.